|
|
| (9 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Metoprolol tartrate#Adult Indications and Dosage]] |
| {{Metoprolol}}
| |
| {{CMG}}
| |
| | |
| ==Indications And Usage==
| |
| | |
| ===Hypertension===
| |
| | |
| Lopressor tablets are indicated for the treatment of [[hypertension]]. They may be used alone or in combination with other antihypertensive agents.
| |
| | |
| ===Angina Pectoris===
| |
| | |
| Lopressor is indicated in the long-term treatment of [[angina pectoris]].
| |
| | |
| ===Myocardial Infarction===
| |
| | |
| Lopressor ampuls and tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute [[myocardial infarction]] to reduce cardiovascular mortality. Treatment with intravenous Lopressor can be initiated as soon as the patient’s clinical condition allows (see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, and WARNINGS).
| |
| Alternatively, treatment can begin within 3-10 days of the acute event (see DOSAGE AND ADMINISTRATION).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOPRESSOR (METOPROLOL TARTRATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Beta blockers]]
| |